WHAT'S HAPPENING
Prediction markets put Democrats at a 72% chance of sweeping Congress on November 3rd. Wall Street didn't wait. The iShares US Aerospace and Defence ETF dropped 16% from July through mid-October while the S&P 500 gained 3.5% over the same period. Northrop Grumman is down 35% from its March peak. Lockheed Martin is down over 20%. The fear: a Democrat-controlled Congress blocks Trump's proposed $500 billion defence budget increase.
YOUR WALLET
If you hold a broad index fund, you've been partially shielded — the S&P 500 still gained 3.5% while defence collapsed. But if your pension or ISA holds the iShares Aerospace and Defence ETF, you're already down 16% on that position. Northrop trades at 17 times forward earnings — a low multiple for a company that raised its 2026 guidance. Defence contractors have record order backlogs. The share price isn't tracking the business. It's tracking a poll.
YOUR WILL
Law of Panic: panic doesn't wait for facts. The market sold defence stocks because a prediction market said Democrats probably win. No vote cast, no budget cut, no contract cancelled. The punishment arrived anyway. Know this: when price moves on probability rather than reality, the instrument isn't measuring a company's worth — it's measuring collective anxiety. Anxiety can be wrong. The person who buys the panic owns the recovery.
THE MOVE
The Sovereign One checks whether the selloff is tracking the business or tracking the narrative. Northrop's backlog hit a record $104.69 billion in Q2. Orders are full. The stock is down 35%. Step 5, the Day After Doctrine: urgency is almost always an illusion engineered to separate the impatient from their ground.
02
Centene Is Up 73% This Year. Your Medicaid Isn't.
The same Democrat odds tanking defence are making health insurers rich. The policy that would save your coverage is already priced into someone else's portfolio.
THE STREETSLAW OF THE LANDLORD™
WHAT'S HAPPENING
Centene, America's largest Medicaid managed-care company, is up 73% year-to-date as Democrat odds rose. The logic: Democrats winning Congress delays or reverses $911 billion in Medicaid cuts baked into Trump's One Big Beautiful Bill Act through 2034. More covered patients means more premium income for Centene. JPMorgan listed Centene as a Blue Wave beneficiary. Man Group flagged it alongside Molina Healthcare as the clearest political plays in healthcare.
YOUR WALLET
Centene closed at $71.24 on October 22nd, up from $64.88 in August — a 9.8% move just since the Democrat surge. Over the full year, it's returned 104%. The Medicaid cuts it profits from delaying would remove $911 billion in federal coverage spending through 2034, hitting around 8 to 10 million low-income Americans. Fewer insured patients means more uncompensated hospital bills. Centene's ACA membership already fell 2.4 million people year-over-year as premiums rose and subsidies expired.
YOUR WILL
Law of the Landlord: someone always owns the pipe the resource flows through. Your healthcare coverage is Centene's revenue stream. When your coverage is cut, Centene restructures and raises premiums on the people who remain. When Democrats look likely to protect that coverage, Centene's stock goes up. Know this: the system isn't choosing between your health and their profit. It built both into the same trade. The people betting on your coverage being saved are betting for their returns, not for you.
THE MOVE
The Sovereign One understands that healthcare stocks move on policy probability, not patient outcomes. If you're uninsured or Medicaid-dependent, the question isn't whether to buy Centene — it's whether to check your state's Medicaid eligibility before cuts arrive. Step 4, Build the Strategic Reserve: margin isn't idle resource, it's the breathing room where genuine leverage lives. Health is the original reserve.
03
Anthropic Filed Its Books. It Lost $8 Billion Running a Company Worth $2 Trillion.
The S-1 is public. Revenue 12x'd in a year. The operating loss grew 2.7x. And two clients you can't name account for a quarter of all income.
THE JUNGLELAW OF THE TRAP™
WHAT'S HAPPENING
Anthropic filed its S-1 — that's the document a company must publish before selling shares to the public — with the SEC on October 26th, targeting a November Nasdaq listing under ticker ANT. Revenue hit $4.585 billion in 2025, up from $386 million in 2024. Operating loss widened from $2.98 billion to $8.06 billion. In Q2 2026 alone, revenue hit $11.5 billion and the company posted its first adjusted operating profit. Goldman Sachs and Morgan Stanley are managing the sale. Target valuation: $1.5 to $2 trillion.
YOUR WALLET
At $2 trillion, Anthropic would be valued at roughly 43 times its annualised Q2 2026 revenue. Amazon and Google's cloud marketplaces generated 47% of 2025 revenue — meaning Anthropic pays distribution fees to the same companies it competes with for compute. Two unnamed clients alone generated nearly 25% of 2025 revenue. Anthropic spent $7.33 billion on compute in 2025 — more than its full-year revenue. It held $20.28 billion cash at year-end. The IPO exists partly because it needs the money to keep operating at scale.
YOUR WILL
Law of the Trap: the deal looks extraordinary until you read what's inside it. The $2 trillion ask on a company that lost $8 billion operating in its best year of growth is a bet that the growth never stops, the two big clients never leave, and Amazon and Google never charge more. Know this: when an IPO prospectus dedicates 90 pages to risk factors and admits the global insurance industry may not cover its potential liability, the hype isn't the product — the hype is the sale mechanism.
THE MOVE
The Sovereign One reads the S-1, not the press release. Anthropic's valuation is 435 times its 2025 revenue. Its Q2 2026 adjusted profit was $559 million on $11.5 billion in revenue — a 4.8% margin, with compute costs still falling fast. The question worth sitting with: are you buying the trajectory, or paying for someone else's exit? Step 6, Internal Intelligence Agency: the most expensive deceptions are never the ones sold outside, but the ones rationalised within.